Clinical Trials · NCT06171152
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
- Phase
- EARLY_Phase 1
- Recruitment status
- Suspended
- Sponsor
- University of Chicago
- Enrollment
- 30
- Start date
- Jan 2024
- Locations
- 1 site, United States
- Primary endpoint
- Change from Baseline in Serum Brain Derived Neurotrophic Factor (BDNF) after 8 Weeks